Naegis Pharmaceuticals Inc.
$135,000.00 CAD
≈ 21 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2019-2020
- Agreement period
- April 1, 2019 – February 28, 2020
- Reference
- nrc-cnrc:172-2019-2020-Q1-927212
Published purpose
This project involves preclinical studies that will be performed to support development of the firm's lead molecule, an inhibitor of leukotriene production, as a potential novel therapy for inflammatory eye diseases.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions